Black Diamond Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Black Diamond Therapeutics, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BLACK DIAMOND THERAPEUTICS. The owner is based in Cambridge, MA.
One Main Street, 10th Floor
Cambridge, MA 02142
Showing of trademarks Trademarks
Trademark Classifications
Black Diamond Therapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Black Diamond Therapeutics, Inc. have?
Black Diamond Therapeutics, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.
What trademark classes does Black Diamond Therapeutics, Inc. file in?
Black Diamond Therapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Black Diamond Therapeutics, Inc.'s most well-known trademarks?
Black Diamond Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as BLACK DIAMOND THERAPEUTICS. These are among 3 currently registered trademarks in the portfolio.
What is Black Diamond Therapeutics, Inc.'s trademark registration success rate?
Black Diamond Therapeutics, Inc. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.